SK

Shrija Konda

Active Director Director DIN 05223734
DIN 05223734 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Sep 2024
Shareholding value •••• Premium profile

About Shrija Konda

Data last updated:

Shrija Konda is a Director at Sai Teja Drugs And Intermidiates Private Limited (since 2024) and Director at Shree Vinayaka Life Sciences Private Limited (since 2024). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹7.26 Cr; the largest is Sai Teja Drugs And Intermidiates Private Limited at ₹5.89 Cr (FY 2025).

DIN 05223734
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2024
Oldest Company Age 26 yrs
Largest company Sai Teja Drugs And Intermidiates Private Limited · ₹5.89 Cr (FY 2025)
Combined revenue ₹7.26 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20242000₹5.89 Cr (FY 2025)Active
Director04 Sep 20242004₹1.36 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Sai Teja Drugs And Intermidiates Private Limited
Shree Vinayaka Life Sciences Private Limited
Premium access

Shareholding and investment profile for Shrija Konda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shrija Konda

Shrija Konda currently holds 2 directorships: Sai Teja Drugs And Intermidiates Private Limited (Director, since 04 Sep 2024, revenue ₹5.89 Cr (FY 2025)); Shree Vinayaka Life Sciences Private Limited (Director, since 04 Sep 2024, revenue ₹1.36 Cr (FY 2025)).

Shrija Konda was first appointed on 04 Sep 2024 as Director at Sai Teja Drugs And Intermidiates Private Limited.

The 2 current companies of Shrija Konda that report revenue have a combined latest revenue of ₹7.26 Cr: Sai Teja Drugs And Intermidiates Private Limited ₹5.89 Cr (FY 2025); Shree Vinayaka Life Sciences Private Limited ₹1.36 Cr (FY 2025).

The current boards of Shrija Konda's companies include Bhargav Reddy Kallam (Sai Teja Drugs And Intermidiates Private Limited), Chandrasekhara Reddy Kallam (Sai Teja Drugs And Intermidiates Private Limited), Latha Kallam (Sai Teja Drugs And Intermidiates Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available